Table II.
Comparisons of clinical characteristics after 6 months’ follow-up
| Variables | GG (n = 183) | GA (n = 63) | AA (n = 9) | P-value |
|---|---|---|---|---|
| Current smoker, n (%) | 37 (20.2) | 10 (15.9) | 2 (22.2) | 0.061 |
| Systolic BP [mm Hg] | 131 ±17 | 129 ±18 | 127 ±13 | 0.174 |
| Diastolic BP [mm Hg] | 72 ±13 | 70 ±15 | 69 ±11 | 0.205 |
| Heart rate [beat per minute] | 73 ±13 | 75 ±14 | 71 ±10 | 0.158 |
| Hemoglobin [g/l] | 13.5 ±1.2 | 13.8 ±1.4 | 13.6 ±1.5 | 0.192 |
| Platelet [× 109/l] | 182 ±41 | 186 ±49 | 193 ±46 | 0.133 |
| Glycated hemoglobin (%) | 6.4 ±1.3 | 6.2 ±1.4 | 6.3 ±1.1 | 0.254 |
| Total cholesterol [mmol/l] | 4.9 ±0.8 | 4.8 ±0.7 | 4.8 ±0.9 | 0.140 |
| Triglyceride [mmol/l]* | 1.8 (0.8–2.8) | 1.8 (0.7–3.2) | 1.7 (0.8–2.9) | 0.302 |
| Creatinine [μmol/l] | 75.2 ±14.3 | 76.6 ±13.7 | 74.4 ±12.9 | 0.115 |
| eGFR [ml/min/1.73 m2] | 81.3 ±15.4 | 82.8 ±13.2 | 83.9 ±14.6 | 0.224 |
| Aspirin, n (%) | 183 (100) | 63 (100) | 9 (100) | 1 |
| Clopidogrel, n (%) | 183 (100) | 63 (100) | 9 (100) | 1 |
| Statins, n (%) | 183 (100) | 63 (100) | 9 (100) | 1 |
| Anti-hypertension, n (%) | 122 (66.7) | 41 (65.1) | 6 (66.7) | 0.104 |
| Anti-diabetes, n (%) | 72 (39.3) | 26 (41.3) | 4 (44.4) | 0.172 |
| Proton pump inhibitor, n (%) | 32 (17.5) | 9 (14.3) | 1 (11.1) | 0.016 |
| Number of stents | 1.9 ±0.5 | 1.8 ±0.6 | 1.6 ±0.5 | 0.260 |
| LAD stenting, n (%) | 121 (66.1) | 42 (66.7) | 6 (66.7) | 0.131 |
| LCX stenting, n (%) | 37 (20.2) | 14 (22.2) | 2 (22.2) | 0.259 |
| RCA stenting, n (%) | 84 (45.9) | 29 (46.0) | 4 (44.4) | 0.207 |
| LM stenting, n (%) | 4 (2.2) | 1 (1.6) | 0 | 0.164 |
| Firebird, n (%) | 70 (38.3) | 24 (38.1) | 3 (33.3) | 0.085 |
| Excel, n (%) | 31 (16.9) | 10 (15.9) | 1 (11.1) | 0.116 |
| Taxus, n (%) | 36 (19.7) | 13 (20.6) | 2 (22.2) | 0.184 |
| Enderver, n (%) | 46 (25.1) | 16 (25.4) | 3 (33.3) | 0.072 |
*
Expressed as median and interquartile range;
BP – blood pressure, eGFR – estimated glomerular filtration rate, LAD – left anterior descending, LCX – left circumflex, RCA – right coronary artery, LM – left main.